Skip to main content
Year archive

Grand Pharmaceutical Group Limited — 2019 filings

All 44 regulatory filings released by Grand Pharmaceutical Group Limited (512) in 2019, sourced directly from the official regulator.

44 Filings
2019 Period
2019 filings (44)
Filing Released Lang
CONNECTED TRANSACTION: RAW MATERIALS PURCHASE AGREEMENT
Capital/Financing Update
2019-12-24 English
CONNECTED TRANSACTION: AN INTELLECTUAL PROPERTY LICENSING AGREEMENT AND RELATED R&D PROJECT ASSIGNMENT
Regulatory Filings
2019-12-18 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2019
Share Issue/Capital Change
2019-12-04 English
CONNECTED TRANSACTION: PURCHASE OF SHARES OF ONCOSEC MEDICAL INCORPORATED - FIRST AMENDMENT TO THE CGP STOCK PURCHASE AGREEMENT AND THE STOCKHOLDERS AGREEMENT
Capital/Financing Update
2019-11-26 English
CONNECTED TRANSACTION: ACQUISITION OF MINORITY INTEREST IN A NON-WHOLLY OWNED SUBSIDIARY
Capital/Financing Update
2019-11-20 English
Voluntary Announcement: The Group Obtained the Global Development and Commercialization Rights for the World-wide First Developed New Parainfluenza Drug
Capital/Financing Update
2019-11-18 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2019
Capital/Financing Update
2019-11-06 English
VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE OF AN INNOVATIVE CORONARY INTERVENTION PRODUCT FOR TWO INDICATIONS AS THE FIRST IN THE PRC MARKET
Regulatory Filings
2019-10-14 English
(1) CONNECTED TRANSACTION PURCHASE OF SHARES OF ONCOSEC MEDICAL INCORPORATED&#x3b; AND (2) CONTINUING CONNECTED TRANSACTION LICENSING ARRANGEMENT BETWEEN GRAND DECADE DEVELOPMENTS LIMITED AND ONCOSEC
Capital/Financing Update
2019-10-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2019
Share Issue/Capital Change
2019-10-08 English
INTERIM REPORT 2019
Interim / Quarterly Report
2019-09-23 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2019
Capital/Financing Update
2019-09-05 English
VOLUNTARY ANNOUNCEMENT: IN RELATION TO THE PRODUCTS NEWLY INCLUDED IN THE 2019 NATIONAL MEDICAL REIMBURSEMENT LIST
Regulatory Filings
2019-08-27 English
2019 INTERIM RESULTS ANNOUNCEMENT
Interim / Quarterly Report
2019-08-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2019
Share Issue/Capital Change
2019-08-06 English
DATE OF BOARD MEETING
Regulatory Filings
2019-08-01 English
POSITIVE PROFIT ALERT
Capital/Financing Update
2019-07-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2019
Share Issue/Capital Change
2019-07-05 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 10 JUNE 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-10 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 10 JUNE 2019
Declaration of Voting Results & Voting Rights Announcements
2019-06-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2019
Share Issue/Capital Change
2019-06-06 English
Next Day Disclosure Return
Share Issue/Capital Change
2019-06-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2019
Share Issue/Capital Change
2019-05-07 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2019-05-03 English
PARTIAL COMPLETION OF THE SUBSCRIPTION OF SHARES BY A CONNECTED PERSON
Share Issue/Capital Change
2019-05-03 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2019-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-29 English
GENERAL MANDATE TO ISSUE SHARES&#x3b; RE-ELECTION OF RETIRING DIRECTORS&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2019-04-29 English
ANNUAL REPORT 2018
Regulatory Filings
2019-04-29 English
COMPLETION OF ACQUISITION OF SHARES OF THE COMPANY BY EMPLOYEES
Director's Dealing
2019-04-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2019
Capital/Financing Update
2019-04-08 English
VOLUNTARY ANNOUNCEMENT: THE SELF-DEVELOPED ORPHAN DRUG VIGABATRIN TO BE INCLUDED IN THE PRIORITY REVIEW AND APPROVAL LIST
Regulatory Filings
2019-03-27 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report
2019-03-26 English
DATE OF BOARD MEETING
Regulatory Filings
2019-03-13 English
VOLUNTARY ANNOUNCEMENT: CFIUS CLEARANCE OF SIRTEX ACQUISITION
Capital/Financing Update
2019-03-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2019
Share Issue/Capital Change
2019-03-06 English
POSITIVE PROFIT ALERT
Earnings Release
2019-03-05 English
VOLUNTARY ANNOUNCEMENT: AN INNOVATIVE MEDICAL EQUIPMENT PRODUCT WAS ENROLLED INTO A SPECIAL REVIEW APPROVAL PROCEDURE
Regulatory Filings
2019-03-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2019
Regulatory Filings
2019-02-12 English
VOLUNTARY ANNOUNCEMENT: OBTAINED AN EXCLUSIVE DISTRIBUTION RIGHT IN PRC FOR A NEW COMPOUND NASAL SPRAY
Capital/Financing Update
2019-02-07 English
POSSIBLE ACQUISITION OF SHARES OF THE COMPANY BY EMPLOYEES
Major Shareholding Notification
2019-01-13 English
Terms of Reference of Nomination Committee
Governance Information
2019-01-11 English
Terms of Reference of Audit Committee
Governance Information
2019-01-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2018
Share Issue/Capital Change
2019-01-07 English